170 Combination of a Nasal Antihistamine Olopatadine and A Leukotriene Receptor Antagonist Montelukast Sodium for the Treatment of Seasonal Allergic Patients not Currently Controlled on Monotherapy Intranasal Antihistamine or a Leukotriene Receptor Antagonist

BACKGROUND: For seasonal Allergic Rhinitis (SAR) patients that remain symptomatic on an intranasal antihistamine, Olopatadine or a leukotriene receptor antagonist Montelukast sodium, the combination of intranasal antihistamine with a leukotriene antagonist Montelukast sodium may provide additional e...

Descripción completa

Detalles Bibliográficos
Autor principal: Nsouli, Safa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization Journal 2012
Materias:
Abstracts of the XXII World Allergy Congress
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512723/
http://dx.doi.org/10.1097/01.WOX.0000411927.81072.07

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512723/
http://dx.doi.org/10.1097/01.WOX.0000411927.81072.07

Ejemplares similares